Use access key #2 to skip to page content.
$8.97 0.00 (0.00%)
10/16/2008 4:00 PM

Tercica, Inc. (TRCA)

CAPS Rating:
*

A biopharmaceutical company focuses on the development and commercialization of new therapeutics for the treatment of short stature and other endocrine disorders.

View All Commentary (TRCA)

Recs

0

Avatar fmrick (< 20) Submitted: 2/05/07 5:50 PM : Underperform Start Price: $5.73 TRCA Score: -96.31

If court rules against them in Feb., this goes to zero pretty quick.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links